PHYTOMEDICAL TO EXPAND ITS RESEARCH ACTIVITIES TO INCLUDE NEW DRUG CANDIDATES

PhytoMedical Technologies, Inc., an early-stage research-based biopharmaceutical company focused on the identification, development, and eventual commercialization of innovative plant-derived pharmaceutical and nutraceutical compounds, today announced its plans to actively pursue the research and development of additional plant derived compounds targeting obesity, various types of cancer and Alzheimer's disease, among others.
Business Wire